|
|
||||||||
Supplement: n3 Fatty Acids: Recommendations for Therapeutics and Prevention |
1 From the Institute of Human Nutrition (RJD, TSW, and TS), the Department of Pediatrics (RJD, TSW, and TS), and the Department of Pathology (TSW), College of Physicians & Surgeons of Columbia University, New York, NY
ABSTRACT
Accumulating evidence in both humans and animal models clearly indicates that a group of very-long-chain polyunsaturated fatty acids, the n3 fatty acids (or omega-3), have distinct and important bioactive properties compared with other groups of fatty acids. n3 Fatty acids are known to reduce many risk factors associated with several diseases, such as cardiovascular diseases, diabetes, and cancer. The mechanisms whereby n3 fatty acids affect gene expression are complex and involve multiple processes. As examples, n3 fatty acids regulate 2 groups of transcription factors, such as sterol-regulatory-element binding proteins and peroxisome proliferator-activated receptors, that are critical for modulating the expression of genes controlling both systemic and tissue-specific lipid homeostasis. Modulation of specific genes by n3 fatty acids and cross-talk between these genes are responsible for many effects of n3 fatty acids.
Key Words: Fatty acid gene expression EPA eicosapentaenoic acid DHA docosahexaenoic acid SREBP sterol-responsive-element binding protein PPAR peroxisome proliferator-activated receptor
This article has been cited by other articles:
![]() |
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Wanten and P. C Calder Immune modulation by parenteral lipid emulsions Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1171 - 1184. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |